$SGMO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SANGAMO THERAPEUTICS, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SANGAMO THERAPEUTICS, INC. Get notifications about new insider transactions in SANGAMO THERAPEUTICS, INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 16 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 19.44 | 42,000 | 816,556 | 3,746,000 | 3.7 M to 3.7 M (+1.13 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 19.33 | 21,000 | 405,930 | 3,704,000 | 3.7 M to 3.7 M (+0.57 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 21.22 | 101,808 | 2,159,989 | 3,683,000 | 3.6 M to 3.7 M (+2.84 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 24.28 | 17,808 | 432,432 | 3,683,000 | 3.7 M to 3.7 M (-0.48 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 23.75 | 49,560 | 1,176,802 | 3,683,000 | 3.7 M to 3.7 M (-1.33 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 23.74 | 34,440 | 817,771 | 3,683,000 | 3.7 M to 3.7 M (-0.93 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 23.02 | 52,161 | 1,200,835 | 3,683,000 | 3.6 M to 3.7 M (+1.44 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 22.76 | 71,319 | 1,623,356 | 3,683,000 | 3.6 M to 3.7 M (+1.97 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 23.40 | 123,480 | 2,889,432 | 3,683,000 | 3.8 M to 3.7 M (-3.24 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 22.30 | 12,522 | 279,180 | 3,683,000 | 3.7 M to 3.7 M (+0.34 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 22.25 | 258,377 | 5,748,552 | 3,683,000 | 3.4 M to 3.7 M (+7.54 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 24.10 | 21,001 | 506,124 | 3,683,000 | 3.7 M to 3.7 M (-0.57 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 24.10 | 40,482 | 975,414 | 3,683,000 | 3.7 M to 3.7 M (-1.09 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Option Exercise | S | 35.00 | 8,275 | 289,625 | 8,275 | ||
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Option Exercise | P | 25.00 | 8,275 | 206,875 | 8,275 | ||
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Option Exercise | S | 30.00 | 8,275 | 248,250 | 8,275 | ||
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Option Exercise | P | 20.00 | 8,275 | 165,500 | 8,275 | ||
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 24.00 | 20,415 | 489,989 | 3,683,000 | 3.7 M to 3.7 M (-0.55 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 23.24 | 241,471 | 5,610,579 | 3,683,000 | 3.9 M to 3.7 M (-6.15 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 23.18 | 31,531 | 730,844 | 3,683,000 | 3.7 M to 3.7 M (-0.85 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 22.56 | 42,000 | 947,533 | 3,683,000 | 3.6 M to 3.7 M (+1.15 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 22.45 | 42,001 | 942,712 | 3,683,000 | 3.6 M to 3.7 M (+1.15 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 18.23 | 16,800 | 306,190 | 3,683,000 | 3.7 M to 3.7 M (-0.45 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 18.21 | 67,200 | 1,223,712 | 3,699,800 | 3.8 M to 3.7 M (-1.78 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 18.10 | 42,000 | 760,145 | 3,767,000 | 3.7 M to 3.8 M (+1.13 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 19.46 | 17,243 | 335,504 | 3,725,000 | 3.7 M to 3.7 M (-0.46 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 19.26 | 14,953 | 287,995 | 3,742,243 | 3.8 M to 3.7 M (-0.40 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 19.90 | 42,000 | 835,724 | 3,757,196 | 3.7 M to 3.8 M (+1.13 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 19.15 | 32,194 | 616,518 | 3,715,196 | 3.7 M to 3.7 M (+0.87 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 18.40 | 35,280 | 649,152 | 3,683,002 | 3.7 M to 3.7 M (-0.95 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 18.39 | 39 | 717 | 3,718,282 | 3.7 M to 3.7 M (0.00 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 18.51 | 6,720 | 124,420 | 3,718,321 | 3.7 M to 3.7 M (-0.18 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 18.11 | 11,172 | 202,278 | 3,725,041 | 3.7 M to 3.7 M (-0.30 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 18.61 | 15,380 | 286,166 | 3,736,213 | 3.8 M to 3.7 M (-0.41 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 18.46 | 15,409 | 284,438 | 3,751,593 | 3.8 M to 3.8 M (-0.41 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 18.04 | 42,000 | 757,621 | 3,767,002 | 3.7 M to 3.8 M (+1.13 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 19.65 | 42,000 | 825,275 | 3,725,002 | 3.7 M to 3.7 M (+1.14 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 18.52 | 34,688 | 642,432 | 3,683,002 | 3.7 M to 3.7 M (-0.93 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 18.42 | 7,312 | 134,683 | 3,717,690 | 3.7 M to 3.7 M (-0.20 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 18.36 | 10,666 | 195,852 | 3,725,002 | 3.7 M to 3.7 M (+0.29 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 18.21 | 17,640 | 321,224 | 3,714,336 | 3.7 M to 3.7 M (+0.48 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 18.17 | 13,694 | 248,752 | 3,696,696 | 3.7 M to 3.7 M (+0.37 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 18.28 | 44,957 | 821,814 | 3,970,562 | 4 M to 4 M (-1.12 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 18.47 | 27,483 | 507,551 | 4,015,519 | 4 M to 4 M (-0.68 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 12.09 | 5,040 | 60,921 | 4,043,002 | 4 M to 4 M (+0.12 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 12.09 | 9,600 | 116,071 | 4,037,962 | 4 M to 4 M (+0.24 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 10.00 | 76,800 | 768,000 | 3,118,218 | 3.2 M to 3.1 M (-2.40 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 9.91 | 76,800 | 761,088 | 3,195,018 | 3.3 M to 3.2 M (-2.35 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 10.00 | 19,200 | 192,000 | 3,271,818 | 3.3 M to 3.3 M (-0.58 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 9.50 | 191,999 | 1,823,031 | 3,291,018 | 3.5 M to 3.3 M (-5.51 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 9.51 | 4,071 | 38,729 | 3,483,017 | 3.5 M to 3.5 M (-0.12 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 9.37 | 5,012 | 46,938 | 3,487,088 | 3.5 M to 3.5 M (-0.14 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 9.60 | 23,042 | 221,203 | 3,492,100 | 3.5 M to 3.5 M (-0.66 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 9.57 | 11,520 | 110,189 | 3,515,142 | 3.5 M to 3.5 M (-0.33 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 9.56 | 76,801 | 734,218 | 3,526,662 | 3.6 M to 3.5 M (-2.13 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 9.85 | 105,522 | 1,039,392 | 3,603,463 | 3.7 M to 3.6 M (-2.85 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 9.85 | 4,532 | 44,640 | 3,603,463 | 3.6 M to 3.6 M (-0.13 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 9.85 | 76,800 | 756,480 | 3,603,463 | 3.7 M to 3.6 M (-2.09 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 9.77 | 23,040 | 225,202 | 3,603,463 | 3.6 M to 3.6 M (-0.64 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 10.02 | 74,035 | 741,498 | 3,626,503 | 3.7 M to 3.6 M (-2.00 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 10.21 | 29,070 | 296,889 | 3,626,503 | 3.7 M to 3.6 M (-0.80 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Sell | S | 10.24 | 19,200 | 196,512 | 3,626,503 | 3.6 M to 3.6 M (-0.53 %) | |
| Feb 18 2015 | SGMO | SANGAMO BIOSCIENCE ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 9.79 | 19,200 | 187,895 | 3,645,703 | 3.6 M to 3.6 M (+0.53 %) | |
| Feb 13 2015 | SGMO | SANGAMO BIOSCIENCE ... | Ramasastry Saira | Director | Option Exercise | M | 5.03 | 10,000 | 50,300 | 14,450 | |
| Feb 13 2015 | SGMO | SANGAMO BIOSCIENCE ... | Ramasastry Saira | Director | Sell | S | 15.00 | 10,000 | 150,000 | 0 | 10 K to 0 (-100.00 %) |
| Feb 13 2015 | SGMO | SANGAMO BIOSCIENCE ... | Ramasastry Saira | Director | Buy | M | 5.03 | 10,000 | 50,300 | 10,000 | 0 to 10 K |
| Feb 12 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 162,000 | |
| Feb 12 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 12.65 | 1,029 | 13,014 | 206,849 | 207.9 K to 206.8 K (-0.50 %) |
| Feb 12 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 12.63 | 971 | 12,264 | 207,878 | 208.8 K to 207.9 K (-0.46 %) |
| Feb 12 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 12.65 | 10,000 | 126,473 | 208,849 | 218.8 K to 208.8 K (-4.57 %) |
| Feb 12 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 10,000 | 34,500 | 218,849 | 208.8 K to 218.8 K (+4.79 %) |
| Feb 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 3,202 | 11,047 | 110,798 | |
| Feb 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 6.82 | 11,798 | 80,462 | 0 | |
| Feb 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 12.93 | 15,000 | 193,950 | 95,376 | 110.4 K to 95.4 K (-13.59 %) |
| Feb 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 3,202 | 11,047 | 110,376 | 107.2 K to 110.4 K (+2.99 %) |
| Feb 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 6.82 | 11,798 | 80,462 | 107,174 | 95.4 K to 107.2 K (+12.37 %) |
| Feb 05 2015 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Option Exercise | M | 6.41 | 2,200 | 14,102 | 5,600 | |
| Feb 05 2015 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Sell | S | 12.70 | 2,200 | 27,940 | 800 | 3 K to 800 (-73.33 %) |
| Feb 05 2015 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Buy | M | 6.41 | 2,200 | 14,102 | 3,000 | 800 to 3 K (+275.00 %) |
| Feb 04 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 5.70 | 7,000 | 39,900 | 48,172 | |
| Feb 04 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 5.35 | 5,000 | 26,750 | 40,000 | |
| Feb 04 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 3.45 | 3,000 | 10,350 | 28,500 | |
| Feb 04 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Sell | S | 12.86 | 15,000 | 192,830 | 116,410 | 131.4 K to 116.4 K (-11.41 %) |
| Feb 04 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 5.70 | 7,000 | 39,900 | 131,410 | 124.4 K to 131.4 K (+5.63 %) |
| Feb 04 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 5.35 | 5,000 | 26,750 | 124,410 | 119.4 K to 124.4 K (+4.19 %) |
| Feb 04 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 3.45 | 3,000 | 10,350 | 119,410 | 116.4 K to 119.4 K (+2.58 %) |
| Jan 16 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 6.82 | 10,000 | 68,200 | 175,000 | |
| Jan 16 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 6.82 | 15,000 | 102,300 | 185,000 | |
| Jan 16 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 14.29 | 10,000 | 142,853 | 235,000 | 245 K to 235 K (-4.08 %) |
| Jan 16 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | M | 6.82 | 10,000 | 68,200 | 245,000 | 255 K to 245 K (-3.92 %) |
| Jan 16 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 14.97 | 1,600 | 23,947 | 235,000 | 236.6 K to 235 K (-0.68 %) |
| Jan 16 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 14.09 | 13,400 | 188,822 | 236,600 | 250 K to 236.6 K (-5.36 %) |
| Jan 16 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Buy | M | 6.82 | 15,000 | 102,300 | 250,000 | 235 K to 250 K (+6.38 %) |
| Jan 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 172,000 | |
| Jan 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 15.87 | 2,000 | 31,740 | 208,849 | 210.8 K to 208.8 K (-0.95 %) |
| Jan 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 15.87 | 10,000 | 158,710 | 210,849 | 220.8 K to 210.8 K (-4.53 %) |
| Jan 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 10,000 | 34,500 | 220,849 | 210.8 K to 220.8 K (+4.74 %) |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Option Exercise | M | 6.41 | 2,200 | 14,102 | 7,800 | |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Sell | S | 15.20 | 2,200 | 33,430 | 800 | 3 K to 800 (-73.33 %) |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Buy | M | 6.41 | 2,200 | 14,102 | 3,000 | 800 to 3 K (+275.00 %) |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | M | 7.77 | 10,000 | 77,700 | 0 | |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | M | 5.03 | 5,000 | 25,150 | 0 | |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 15.10 | 15,000 | 226,550 | 214,660 | 229.7 K to 214.7 K (-6.53 %) |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Buy | M | 7.77 | 10,000 | 77,700 | 229,660 | 219.7 K to 229.7 K (+4.55 %) |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Buy | M | 5.03 | 5,000 | 25,150 | 219,660 | 214.7 K to 219.7 K (+2.33 %) |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP, Research & CSO | Option Exercise | M | 13.98 | 4,000 | 55,920 | 78,000 | |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP, Research & CSO | Option Exercise | M | 5.70 | 3,000 | 17,100 | 55,172 | |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP, Research & CSO | Option Exercise | M | 5.35 | 5,000 | 26,750 | 45,000 | |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP, Research & CSO | Option Exercise | M | 3.45 | 3,000 | 10,350 | 31,500 | |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP, Research & CSO | Sell | S | 15.78 | 15,000 | 236,664 | 116,410 | 131.4 K to 116.4 K (-11.41 %) |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP, Research & CSO | Buy | M | 13.98 | 4,000 | 55,920 | 131,410 | 127.4 K to 131.4 K (+3.14 %) |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP, Research & CSO | Buy | M | 5.70 | 3,000 | 17,100 | 127,410 | 124.4 K to 127.4 K (+2.41 %) |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP, Research & CSO | Buy | M | 5.35 | 5,000 | 26,750 | 124,410 | 119.4 K to 124.4 K (+4.19 %) |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP, Research & CSO | Buy | M | 3.45 | 3,000 | 10,350 | 119,410 | 116.4 K to 119.4 K (+2.58 %) |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 6.82 | 1,500 | 10,230 | 11,798 | |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 15.66 | 600 | 9,394 | 95,376 | 96 K to 95.4 K (-0.63 %) |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 15.17 | 14,400 | 218,460 | 95,976 | 110.4 K to 96 K (-13.05 %) |
| Jan 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 6.82 | 15,000 | 102,300 | 110,376 | 95.4 K to 110.4 K (+15.73 %) |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Option Exercise | A | 14.07 | 75,000 | 1,055,250 | 75,000 | |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Payment of Exercise | F | 14.74 | 41,743 | 615,217 | 138,146 | 179.9 K to 138.1 K (-23.20 %) |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Grant | A | 0.00 | 37,500 | 0 | 179,889 | 142.4 K to 179.9 K (+26.34 %) |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 4.11 | 25,000 | 102,750 | 0 | |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | A | 14.07 | 250,000 | 3,517,500 | 250,000 | |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 14.79 | 16,000 | 236,677 | 323,467 | 339.5 K to 323.5 K (-4.71 %) |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 16.47 | 9,000 | 148,235 | 339,467 | 348.5 K to 339.5 K (-2.58 %) |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Buy | M | 4.11 | 25,000 | 102,750 | 348,467 | 323.5 K to 348.5 K (+7.73 %) |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Payment of Exercise | F | 14.74 | 96,533 | 1,422,723 | 323,467 | 420 K to 323.5 K (-22.98 %) |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Grant | A | 0.00 | 125,000 | 0 | 420,000 | 295 K to 420 K (+42.37 %) |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | M | 5.03 | 5,000 | 25,150 | 5,000 | |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | M | 6.41 | 10,000 | 64,100 | 0 | |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 16.28 | 10,000 | 162,829 | 214,660 | 224.7 K to 214.7 K (-4.45 %) |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Buy | M | 5.03 | 5,000 | 25,150 | 229,660 | 224.7 K to 229.7 K (+2.23 %) |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Buy | M | 6.41 | 10,000 | 64,100 | 224,660 | 214.7 K to 224.7 K (+4.66 %) |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | A | 14.07 | 50,000 | 703,500 | 50,000 | |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Payment of Exercise | F | 14.74 | 27,480 | 405,006 | 95,376 | 122.9 K to 95.4 K (-22.37 %) |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Grant | A | 0.00 | 25,000 | 0 | 122,856 | 97.9 K to 122.9 K (+25.55 %) |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | A | 14.07 | 75,000 | 1,055,250 | 75,000 | |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Payment of Exercise | F | 14.74 | 30,437 | 448,587 | 116,410 | 146.8 K to 116.4 K (-20.73 %) |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Grant | A | 0.00 | 37,500 | 0 | 146,847 | 109.3 K to 146.8 K (+34.29 %) |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 14.07 | 75,000 | 1,055,250 | 750,000 | |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Payment of Exercise | F | 14.74 | 40,004 | 589,587 | 210,849 | 250.9 K to 210.8 K (-15.95 %) |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 0.00 | 37,500 | 0 | 250,853 | 213.4 K to 250.9 K (+17.58 %) |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | Mento Steven J | Director | Option Exercise | M | 4.10 | 10,000 | 41,000 | 0 | |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | Mento Steven J | Director | Sell | S | 15.00 | 6,354 | 95,310 | 28,715 | 35.1 K to 28.7 K (-18.12 %) |
| Dec 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | Mento Steven J | Director | Buy | M | 4.10 | 10,000 | 41,000 | 35,069 | 25.1 K to 35.1 K (+39.89 %) |
| Dec 09 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 6.82 | 15,000 | 102,300 | 26,798 | |
| Dec 09 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 11.21 | 15,000 | 168,197 | 97,856 | 112.9 K to 97.9 K (-13.29 %) |
| Dec 09 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 6.82 | 15,000 | 102,300 | 112,856 | 97.9 K to 112.9 K (+15.33 %) |
| Dec 09 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | M | 4.54 | 10,000 | 45,400 | 0 | |
| Dec 09 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 12.00 | 10,000 | 120,000 | 214,660 | 224.7 K to 214.7 K (-4.45 %) |